If your pharmacist has told you they're "out of duloxetine" twice in the last year, you're not imagining a pattern. But the word "shortage" doesn't quite fit what's happening. What's actually going on is a run of manufacturer recalls tied to one specific impurity, layered on top of a drug that gets prescribed to millions of people for depression, anxiety, nerve pain, and fibromyalgia. Here's what's true, what isn't, and what actually works if you're standing at the counter with an empty bottle.
1. Is Duloxetine Officially in a Shortage?
Technically, no. Check the FDA's Drug Shortages Database or the ASHP Drug Shortage Resource Center today and you won't find standard duloxetine delayed-release capsules on either list. That matters for how insurers and pharmacies process the situation on paper, but it doesn't explain why your specific pharmacy handed you an empty bag.
What's actually happening: since late 2024, the FDA has repeatedly flagged duloxetine lots for containing N-nitroso-duloxetine, a nitrosamine byproduct that can form during manufacturing, at levels above the agency's recommended limit. Each recall is voluntary, initiated by the distributor, and limited to specific lot numbers, not the entire drug supply. Nitrosamines are considered probable carcinogens with long-term exposure, and the FDA has been clear that the immediate health risk from any single affected bottle is low. Patients are told not to stop taking duloxetine over a recall without talking to a prescriber first.
So the honest version is this: duloxetine as a molecule is not scarce. Dozens of generic manufacturers make it. What keeps happening is that specific labelers, mainly Breckenridge Pharmaceutical and Quallent Pharmaceuticals Health, both distributing capsules manufactured by Towa Pharmaceutical Europe in Spain, keep getting hit with the same impurity issue. If your regular pharmacy leaned heavily on one of those suppliers, you feel a shortage even though one doesn't officially exist.
2. Why You're Still Running Into Empty Shelves
Three things are stacking on top of each other here.
First, duloxetine is genuinely one of the most-prescribed medications in the country. It covers major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain, so a huge and varied patient population relies on it.
Second, nitrosamine testing across the generic drug industry got much stricter after the valsartan contamination cases a few years back, and manufacturers making older, complex molecules like duloxetine have kept turning up trace impurities during routine batch testing.
Third, a single pharmacy or small chain often buys the bulk of its stock from one or two wholesalers. When a recall hits that wholesaler's supplier, the shelf goes empty locally even though a pharmacy three miles away, stocked by a different distributor, never noticed a thing.
Put together, you get a drug that is not in a national shortage but produces a very real, very local experience of "they don't have it" over and over again.
3. Timeline: Recalls and Recovery, 2013–2026
| Date | Event |
|---|---|
| 2013 | Generic duloxetine launches after the Cymbalta patent expires, quickly becoming a low-cost standard |
| 2020 | FDA approves Drizalma Sprinkle, a sprinkle-capsule version made by Sun Pharma for patients who can't swallow pills |
| 2022–2024 | Sun Pharma manufacturing disruptions cause a genuine, ASHP-listed Drizalma Sprinkle shortage |
| October 2024 | First nitrosamine recall: Towa Pharmaceutical Europe capsules distributed by Breckenridge Pharmaceutical, roughly 7,100 bottles of 20 mg capsules |
| December 2024 | Second, broader recall covering additional strengths and lots shipped between March 2023 and August 2024 |
| Mid-2024 | Sun Pharma resumes full Drizalma Sprinkle production; ASHP listing improves |
| November 2025 | Third recall: Quallent Pharmaceuticals Health, distributing Towa-manufactured 60 mg capsules under the Breckenridge label, classified Class II by the FDA in December 2025 |
| June 2026 | Fourth recall: Breckenridge Pharmaceutical pulls a 30 mg lot for the same nitrosamine issue |
| August 2026 | Standard duloxetine capsules remain off the FDA and ASHP shortage lists; Drizalma Sprinkle supply is stable |
4. Current Availability by Product
| Product | Manufacturer | Status |
|---|---|---|
| Generic duloxetine DR capsules (most manufacturers) | Multiple, 15+ generic makers | Widely available |
| Duloxetine 60 mg, 1000-ct bottles | Quallent / Breckenridge (mfg. Towa) | Specific lots recalled; other bottles of the same strength unaffected |
| Duloxetine 30 mg, various lots | Breckenridge (mfg. Towa) | Lot 241180C recalled June 2026; other manufacturers' 30 mg unaffected |
| Drizalma Sprinkle (20/30/40/60 mg) | Sun Pharma | Available; stable since 2024 |
| Brand-name Cymbalta | Eli Lilly | Available, rarely dispensed since generics exist |
Notice the pattern: it's not duloxetine that's scarce, it's specific bottles from specific labelers. A pharmacist who checks their wholesaler catalog can almost always find a strength from a manufacturer that hasn't been touched by a recall.
Cymbalta Recall 2026: Latest Lot Numbers
While brand-name Cymbalta (Eli Lilly) has not been recalled, multiple generic duloxetine manufacturers have faced recalls since October 2024. Here are the lot numbers to check on your bottle as of August 2026:
| Manufacturer | Lot Number | Strength | Expiration |
|---|---|---|---|
| Asclemed USA | 050725G-30, 050725F-30 | 30 mg | Jun 30, 2026 |
| Breckenridge (Towa) | 241180C | 30 mg | Apr 2027 |
| Quallent / Breckenridge (Towa) | 240947C, 240962C, 240534C, 240977C | 60 mg | Various 2025–2026 |
| Rising Health | Multiple lots (DT6023059A, DT6023060A, etc.) | 60 mg | Nov 2024 – Dec 2025 |
How to Check If Your Duloxetine Bottle Is Recalled
- Find your lot number on the bottle label — usually near the expiration date.
- Compare against the table above. If your lot matches, don't panic. The FDA classifies these as Class II recalls, meaning the risk of serious harm is remote.
- Call your pharmacy to confirm whether your specific bottle is affected. Some lots were distributed only to specific wholesalers.
- Don't stop taking duloxetine without talking to your prescriber. The FDA advises against abrupt discontinuation.
Duloxetine Recall 2026: Check Your Lot Number
| Date | Company | Product / Lot | Reason |
|---|---|---|---|
| Oct 10, 2024 | Breckenridge Pharmaceutical (mfg. Towa) | 20 mg, Lot 220128, 500-ct bottles | N-nitroso-duloxetine above FDA limit |
| Dec 2024 | Rising Health LLC | 20/30/60 mg, lots shipped Mar 2023–Aug 2024 | N-nitroso-duloxetine above interim limit |
| Nov 21, 2025 | Quallent Pharmaceuticals Health / Breckenridge (mfg. Towa) | 60 mg, 1000-ct, lots 240947C, 240962C, 240534C, 240977C | N-nitroso-duloxetine above FDA limit; Class II, Dec 3, 2025 |
| Jun 2026 | Breckenridge Pharmaceutical | 30 mg, Lot 241180C, exp. April 2027 | N-nitroso-duloxetine above FDA limit |
All four recalls were voluntary, all four were classified Class II by the FDA, meaning the risk of serious harm is low, and none have been linked to reported adverse events. If your bottle's NDC or lot number matches one of these, don't stop taking it on your own. Call your pharmacist to confirm, and ask your prescriber whether a short bridge supply makes sense while you swap to an unaffected lot.
6. Alternatives If Duloxetine Isn't Available
Before reaching for a different drug entirely, ask your pharmacist to check other manufacturers of duloxetine first, since that solves most cases without any prescription change. If duloxetine genuinely isn't obtainable in time, these are the SNRIs prescribers most often consider instead.
| Alternative | Best fit | Key consideration |
|---|---|---|
| Venlafaxine (Effexor XR) | Depression, GAD, panic disorder, social anxiety | Broadest range of indications; not FDA-approved for pain |
| Desvenlafaxine (Pristiq) | Depression, patients needing simpler once-daily dosing | Fewer drug interactions; a reasonable option with liver concerns |
| Milnacipran (Savella) | Fibromyalgia specifically | FDA-approved for fibromyalgia; requires twice-daily dosing |
| Levomilnacipran (Fetzima) | Major depressive disorder | Most norepinephrine-selective SNRI; approved for MDD only |
Switching temporarily makes sense when...
- You're within a day or two of running out with no unaffected duloxetine bottle in reach
- Your prescriber agrees the alternative covers your specific diagnosis
- You can get a follow-up appointment once duloxetine is back in stock
It's worth avoiding when...
- You're being treated for nerve pain or musculoskeletal pain and the alternative isn't approved for that use
- You have supply for another week, since a manufacturer switch will likely resolve it without changing drugs at all
- You haven't confirmed insurance coverage for the new medication yet
7. Switching Antidepressants Safely
Never switch SNRIs on your own. Duloxetine has a short half-life, and stopping it abruptly, even for a few days, can trigger discontinuation symptoms: dizziness, nausea, irritability, and the sensation many patients describe as brain zaps. This risk is higher at higher doses and after longer-term use. A prescriber can arrange a short overlap or taper if a switch is genuinely necessary, which is far gentler than an unplanned gap.
For example, a patient on 60 mg duloxetine for fibromyalgia who can't locate any bottle for a week is a very different case than a patient on 30 mg for mild anxiety who has a week's cushion left. The first case usually needs a same-week call to the prescriber's office. The second case usually resolves with a phone call to two more pharmacies.
8. Step-by-Step: What to Do If Your Pharmacy Is Out
Ask exactly which manufacturer they're missing
Pharmacists can usually tell you if it's a specific labeler's stock that's out, not duloxetine as a whole. That single question often ends the search right there.
Call two or three nearby pharmacies before assuming it's everywhere
Independent pharmacies in particular often source from a wholesaler untouched by whichever recall is active that month.
Ask about a partial fill
If a pharmacy has a few days' worth on hand but not a full 30-day supply, ask for a partial fill now and the rest once new stock arrives.
Loop in your prescriber once you're down to a few days
Don't wait until the bottle is empty. A quick call gives your prescriber time to send an e-prescription to a pharmacy with confirmed stock or arrange a short bridge supply.
Don't stop cold if you truly can't get any
If every option has failed and you're out, tell your prescriber that day. A short, supervised taper or temporary alternative is much safer than going without.
9. What Duloxetine Actually Costs in 2026
Generic duloxetine is one of the more affordable antidepressants on the market, though price still swings a lot by pharmacy.
- Generic duloxetine, no insurance, no coupon: roughly $30 to $230 for a 30-day supply, depending on strength, quantity, and pharmacy.
- With a free discount card from a service compared in our Inside Rx vs SingleCare comparison: typically under $20 at most major chains.
- Brand-name Cymbalta: often $285 to $470 a month, and rarely covered by insurance since a generic exists.
- Mail-order and low-cost pharmacies: some patients find lower, more stable pricing through mail-order options, which is worth comparing using a drug price checker before committing to one pharmacy.
Price comparison matters here specifically because it isn't fixed. Two pharmacies three blocks apart can differ by $100 or more for the exact same generic bottle, so checking before you fill is worth the two minutes it takes.
10. Comparing Cost-Help Options
Because generic duloxetine is already inexpensive, most patients don't need a formal patient assistance program. Where things get confusing is knowing which option actually applies to your situation. Here's how the main ones stack up.
Eligibility Comparison
| Option | Who qualifies |
|---|---|
| Free discount cards (GoodRx, Inside Rx, SingleCare) | Anyone, insured or not — no application or income proof required |
| Lilly Cares Foundation | Uninsured or underinsured patients prescribed brand-name Cymbalta specifically, within income limits |
| NeedyMeds / Rx Outreach | Income-eligible patients, generic and brand medications, varies by program |
| State Pharmaceutical Assistance Programs | Varies by state; often seniors, disabled residents, or low-income adults |
| Medicare Extra Help (Low-Income Subsidy) | Medicare Part D enrollees who meet income and asset limits |
Income Limit Comparison
| Option | General income guideline |
|---|---|
| Discount cards | No income limit |
| Lilly Cares Foundation | Typically set as a multiple of the federal poverty level; check Lilly Cares directly for the current threshold |
| NeedyMeds programs | Varies widely by program; searchable at NeedyMeds |
| Medicare Extra Help | Updated annually by the Social Security Administration; confirm current limits at Medicare.gov before assuming you don't qualify |
Covered Medications Comparison
| Option | Covers generic duloxetine? | Covers brand Cymbalta? |
|---|---|---|
| Discount cards | Yes | Rarely needed since generic is cheaper |
| Lilly Cares Foundation | No | Yes |
| NeedyMeds / Rx Outreach | Yes, on many program listings | Sometimes |
| Medicare Extra Help | Yes | Yes |
Application, Approval, and Renewal
| Option | How to apply | Typical approval time | Renewal |
|---|---|---|---|
| Discount cards | Show a code or app at the register — no application | Instant | None needed |
| Lilly Cares Foundation | Prescriber and patient complete a joint application with income documentation | 2 to 4 weeks | Annual reapplication |
| NeedyMeds programs | Varies; many require a short online form and proof of income | 1 to 3 weeks | Varies by program |
| Medicare Extra Help | Apply through the Social Security Administration or Medicare.gov | 4 to 6 weeks | Annual review; some beneficiaries are auto-renewed |
Common Mistakes to Avoid
- Assuming a discount card requires signing up first. Most work the moment you show the code at checkout, with no account needed.
- Assuming Lilly Cares covers your generic bottle. Brand-manufacturer programs almost always cover the brand product only, not the generic version pharmacies dispense by default.
- Using the same discount card everywhere out of habit. Prices differ by pharmacy and change often, so comparing before every fill can save real money.
- Waiting until the pharmacy counter to ask about help. Calling ahead gives a pharmacist time to check other manufacturers or apply a coupon before you're standing there.
- Letting a patient assistance renewal lapse. Missing an annual renewal deadline can create an unexpected coverage gap right when you need it least.
11. Decision Tree: What Should You Do Right Now?
Ask about a bridge supply or a short-term alternative rather than stopping duloxetine without a plan.
Related: Adderall Shortage 2026: Pharmacy Availability & Alternatives
Another commonly prescribed medication with a similar pattern of local stockouts driven by supplier-specific issues rather than a true national shortage.
Need help paying for duloxetine or another prescription?
